Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations

被引：8
|
作者：
Claudiani, Simone [1 ,2 ]
Apperley, Jane F. [1 ,2 ]
Khan, Afzal [2 ]
Khorashad, Jamshid [2 ]
Milojkovic, Dragana [1 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Dept Haematol, London, England
[2] Imperial Coll London, Hammersmith Hosp, Dept Immun & Inflammat, Ctr Haematol,Fac Med, London, England
来源：
HAEMATOLOGICA | 2020年 / 105卷 / 05期
关键词：
MOLECULAR RESPONSE; CLINICAL-PRACTICE; INHIBITORS; IMATINIB; DISCONTINUATION; RECOMMENDATIONS; GUIDELINES; DASATINIB;
D O I：
10.3324/haematol.2019.234179
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E225 / E227
页数：3
相关论文
共 50 条
  • [21] BCR::ABL1 digital PCR for treatment-free remission prediction in chronic myeloid leukemia patients: An individual participant data meta-analysis
    Kockerols, Camille
    Valk, Peter J. M.
    Dulucq, Stephanie
    Nicolini, Franck-Emmanuel
    Mahon, Francois-Xavier
    Atallah, Ehab
    Mauro, Michael J.
    Radich, Jerald P.
    Bernardi, Simona
    Russo, Domenico
    Farina, Mirko
    Mori, Silvia
    Gambacorti-Passerini, Carlo
    Civettini, Ivan
    Lu, Liu
    Yeung, David
    Branford, Susan
    Colafigli, Gioia
    Breccia, Massimo
    Hogenbirk, Pauline
    van Rosmalen, Joost
    Cornelissen, Jan J.
    Westerweel, Peter E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) : 1632 - 1635
  • [22] Treatment value of second-generation BCR-ABL1 tyrosine kinase inhibitors compared with imatinib to achieve treatment-free remission in patients with chronic myeloid leukaemia: a modelling study
    Shih, Ya-Chen Tina
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    LANCET HAEMATOLOGY, 2019, 6 (08): : E398 - E408
  • [23] Relevance of treatment-free remission recommendations in chronic phase chronic leukemia patients treated with frontline tyrosine kinase inhibitors
    Etienne, Gabriel
    Faberes, Carole
    Bauduer, Frederic
    Adiko, Didier
    Lifermann, Francois
    Dagada, Corinne
    Lenoir, Caroline
    Schmitt, Anna
    Klein, Emilie
    Fort, Marie-Pierre
    Bijou, Fontanet
    Turcq, Beatrice
    Robbesyn, Fanny
    Durrieu, Francoise
    Versmee, Laura
    Madene, Samia
    Moldovan, Marius
    Katsahian, Sandrine
    Charles-Nelson, Anais
    Lascaux, Axelle
    Mahon, Francois-Xavier
    Dulucq, Stephanie
    CANCER MEDICINE, 2021, 10 (11): : 3635 - 3645
  • [24] Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia
    Haddad, Fadi
    Kantarjian, Hagop
    Issa, Ghayas C.
    Jabbour, Elias
    Sasaki, Koji
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1714 - 1717
  • [25] Incidence and clinical importance of BCR-ABL1 mutations in Iranian patients with chronic myeloid leukemia on imatinib
    Rostami, Golale
    Hamid, Mohammad
    Yaran, Majid
    Khani, Mohsen
    Karimipoor, Morteza
    JOURNAL OF HUMAN GENETICS, 2015, 60 (05) : 253 - 258
  • [26] Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia
    Fujioka, Yuki
    Sugiyama, Daisuke
    Matsumura, Itaru
    Minami, Yosuke
    Miura, Masatomo
    Atsuta, Yoshiko
    Ohtake, Shigeki
    Kiyoi, Hitoshi
    Miyazaki, Yasushi
    Nishikawa, Hiroyoshi
    Takahashi, Naoto
    CANCERS, 2021, 13 (23)
  • [27] Considerations for Successful Treatment-free Remission in Chronic Myeloid Leukemia
    Goldberg, Stuart L.
    Savona, Michael
    Mauro, Michael J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (02) : 98 - 105
  • [28] Patient perceptions of treatment-free remission in chronic myeloid leukemia
    Sanchez, Lucia A. Villemagne
    O'Callaghan, Clare
    Gough, Karla
    Hall, Karen
    Kashima, Yoshihisa
    Seymour, John F.
    Schofield, Penelope
    Ross, David M.
    LEUKEMIA & LYMPHOMA, 2018, 59 (02) : 406 - 415
  • [29] Treatment-free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors
    Haddad, Fadi G.
    Sasaki, Koji
    Issa, Ghayas C.
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kadia, Tapan
    Cortes, Jorge
    Konopleva, Marina
    Pemmaraju, Naveen
    Alvarado, Yesid
    Yilmaz, Musa
    Borthakur, Gautam
    DiNardo, Courtney
    Jain, Nitin
    Daver, Naval
    Short, Nicholas J.
    Jabbour, Elias
    Kantarjian, Hagop
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) : 856 - 864
  • [30] Use of direct sequencing for detection of mutations in the BCR-ABL kinase domain in Slovak patients with chronic myeloid leukemia
    Strhakova, L.
    Bujalkova, M. Gerykova
    Hojsikova, I.
    Lukackova, R.
    Behulova, R.
    Mistrik, M.
    Repiska, V.
    NEOPLASMA, 2011, 58 (06) : 548 - 553
12345